MedTech Translation: The Linguistic Precision the Medical Device Sector Demands
MedTech translation is not simply a matter of transferring technical information from one language to another, but of meeting the linguistic and regulatory requirements applicable in each market.
Linguistic validation in clinical trials
In multicentre clinical trials, no result can be considered reliable if patients do not fully understand what they are being asked. This is the challenge addressed by linguistic validation: a methodological process that ensures a clinical instrument —such as a questionnaire, informed consent form or
Pharmaceutical translation: why precision can determine a product launch
A clinical trial can take years to generate robust results. A regulatory submission may go through months of assessment. And yet, all that work can be delayed for a reason that rarely makes headlines: a poorly managed pharmaceutical translation. In the pharmaceutical industry, translation is
What Does Translation Proofreading Involve and Why It’s Not an Optional Extra
In specialised translation, proofreading is often seen as the final administrative step in the process – little more than a last minute check to catch typos before delivery. In reality, its role goes far beyond that. In industries such as pharmaceuticals, medical devices, biotechnology, clinical
Patient Safety and Regulatory Compliance through Medical Translation
In the healthcare sector, linguistic accuracy is not merely a matter of quality—it is an ethical, clinical, and legal imperative. A misinterpreted figure in a clinical trial protocol, a missing contraindication, or an ambiguous instruction in a high-risk healthcare product can have serious consequences for patient safety.
How the EU AI Act is Reshaping Innovation in Healthcare Products
The healthcare product sector is experiencing a technological transformation like never before. Algorithms analysing radiology images, natural language models summarising complex clinical records—the use of artificial intelligence (AI) is no longer a future promise but a central driver of operational efficiency. Yet the introduction of
How to Prepare IFU Translations for an MDR Audit
Under the EU Medical Device Regulation, the Instructions for Use (IFU) are no longer just supporting documentation—they are a core part of the safety information provided with the product. For Regulatory Affairs, Quality and Marketing teams, this represents a shift in mindset. A translation error
From SmPC to EMA Approval: 5 Steps to Risk-Free Pharmaceutical Translation
In the European regulatory environment, precision is not just a matter of linguistic quality—it is a compliance requirement. An error in the translation of a Summary of Product Characteristics (SmPC), Patient Information Leaflet (PIL), or labelling can trigger requests for clarification during the review process by the
The future of audiovisual content in Life Sciences: accessibility as a strategic challenge
Audiovisual accessibility is no longer an emerging trend in the healthcare sector. Since 2025, it has become a strategic imperative. The entry into force of the European Accessibility Act (EAA) has fundamentally reshaped the landscape for pharmaceutical, biotechnology and MedTech companies operating across Europe. What
The Risks of Using AI in Regulatory Dossier Translation: Hallucinations and Critical Errors
AI is rapidly reshaping how life sciences organisations work — and translation is no exception. Faced with ever-growing submission volumes, compressed timelines and global programmes that rarely run sequentially, many Regulatory Affairs teams are understandably asking the same question: can AI help us translate faster, and still submit with confidence? The short
Translation
